0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Oral Blood Glucose Regulators - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-19K14366
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Oral Blood Glucose Regulators Market Research Report 2023
BUY CHAPTERS

Oral Blood Glucose Regulators - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-19K14366
Report
October 2024
Pages:140
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Oral Blood Glucose Regulators - Market Size

The global market for Oral Blood Glucose Regulators was estimated to be worth US$ 61200 million in 2023 and is forecast to a readjusted size of US$ 131610 million by 2030 with a CAGR of 12.7% during the forecast period 2024-2030

Oral Blood Glucose Regulators - Market

Oral Blood Glucose Regulators - Market

Oral Blood Glucose Regulators are medications that are taken by mouth to manage blood sugar levels in people with type 2 diabetes.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oral Blood Glucose Regulators, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Oral Blood Glucose Regulators by region & country, by Type, and by Application.
The Oral Blood Glucose Regulators market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Blood Glucose Regulators.
Market Segmentation

Scope of Oral Blood Glucose Regulators - Market Report

Report Metric Details
Report Name Oral Blood Glucose Regulators - Market
Forecasted market size in 2030 US$ 131610 million
CAGR 12.7%
Forecasted years 2024 - 2030
Segment by Type:
  • Biguanides
  • Sulfonylureas
  • Meglitinides
  • Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
  • SGLT2 Inhibitors
  • Thiazolidinediones
  • Alpha-Glucosidase Inhibitors
  • Other
Segment by Application
  • Hospital
  • Clinic
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bayer, Merck, Novartis, Huadong Medicine, Sanofi, Novo Nordisk, Servier, Takeda Pharmaceutical, Luye Pharmaceutical, Taiji Group, CR Double-Crane, AstraZeneca, Boehringer Ingelheim, Qilu Pharmaceutical, Jiangsu Deyuan Pharmaceutical, CTTQ
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Oral Blood Glucose Regulators manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Oral Blood Glucose Regulators in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Oral Blood Glucose Regulators in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Oral Blood Glucose Regulators - Market size in 2030?

Ans: The Oral Blood Glucose Regulators - Market size in 2030 will be US$ 131610 million.

Who are the main players in the Oral Blood Glucose Regulators - Market report?

Ans: The main players in the Oral Blood Glucose Regulators - Market are Bayer, Merck, Novartis, Huadong Medicine, Sanofi, Novo Nordisk, Servier, Takeda Pharmaceutical, Luye Pharmaceutical, Taiji Group, CR Double-Crane, AstraZeneca, Boehringer Ingelheim, Qilu Pharmaceutical, Jiangsu Deyuan Pharmaceutical, CTTQ

What are the Application segmentation covered in the Oral Blood Glucose Regulators - Market report?

Ans: The Applications covered in the Oral Blood Glucose Regulators - Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Oral Blood Glucose Regulators - Market report?

Ans: The Types covered in the Oral Blood Glucose Regulators - Market report are Biguanides, Sulfonylureas, Meglitinides, Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, SGLT2 Inhibitors, Thiazolidinediones, Alpha-Glucosidase Inhibitors, Other

1 Market Overview
1.1 Oral Blood Glucose Regulators Product Introduction
1.2 Global Oral Blood Glucose Regulators Market Size Forecast
1.2.1 Global Oral Blood Glucose Regulators Sales Value (2019-2030)
1.2.2 Global Oral Blood Glucose Regulators Sales Volume (2019-2030)
1.2.3 Global Oral Blood Glucose Regulators Sales Price (2019-2030)
1.3 Oral Blood Glucose Regulators Market Trends & Drivers
1.3.1 Oral Blood Glucose Regulators Industry Trends
1.3.2 Oral Blood Glucose Regulators Market Drivers & Opportunity
1.3.3 Oral Blood Glucose Regulators Market Challenges
1.3.4 Oral Blood Glucose Regulators Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Oral Blood Glucose Regulators Players Revenue Ranking (2023)
2.2 Global Oral Blood Glucose Regulators Revenue by Company (2019-2024)
2.3 Global Oral Blood Glucose Regulators Players Sales Volume Ranking (2023)
2.4 Global Oral Blood Glucose Regulators Sales Volume by Company Players (2019-2024)
2.5 Global Oral Blood Glucose Regulators Average Price by Company (2019-2024)
2.6 Key Manufacturers Oral Blood Glucose Regulators Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Oral Blood Glucose Regulators Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Oral Blood Glucose Regulators
2.9 Oral Blood Glucose Regulators Market Competitive Analysis
2.9.1 Oral Blood Glucose Regulators Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Oral Blood Glucose Regulators Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Blood Glucose Regulators as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Biguanides
3.1.2 Sulfonylureas
3.1.3 Meglitinides
3.1.4 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
3.1.5 SGLT2 Inhibitors
3.1.6 Thiazolidinediones
3.1.7 Alpha-Glucosidase Inhibitors
3.1.8 Other
3.2 Global Oral Blood Glucose Regulators Sales Value by Type
3.2.1 Global Oral Blood Glucose Regulators Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Oral Blood Glucose Regulators Sales Value, by Type (2019-2030)
3.2.3 Global Oral Blood Glucose Regulators Sales Value, by Type (%) (2019-2030)
3.3 Global Oral Blood Glucose Regulators Sales Volume by Type
3.3.1 Global Oral Blood Glucose Regulators Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Oral Blood Glucose Regulators Sales Volume, by Type (2019-2030)
3.3.3 Global Oral Blood Glucose Regulators Sales Volume, by Type (%) (2019-2030)
3.4 Global Oral Blood Glucose Regulators Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Other
4.2 Global Oral Blood Glucose Regulators Sales Value by Application
4.2.1 Global Oral Blood Glucose Regulators Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Oral Blood Glucose Regulators Sales Value, by Application (2019-2030)
4.2.3 Global Oral Blood Glucose Regulators Sales Value, by Application (%) (2019-2030)
4.3 Global Oral Blood Glucose Regulators Sales Volume by Application
4.3.1 Global Oral Blood Glucose Regulators Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Oral Blood Glucose Regulators Sales Volume, by Application (2019-2030)
4.3.3 Global Oral Blood Glucose Regulators Sales Volume, by Application (%) (2019-2030)
4.4 Global Oral Blood Glucose Regulators Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Oral Blood Glucose Regulators Sales Value by Region
5.1.1 Global Oral Blood Glucose Regulators Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Oral Blood Glucose Regulators Sales Value by Region (2019-2024)
5.1.3 Global Oral Blood Glucose Regulators Sales Value by Region (2025-2030)
5.1.4 Global Oral Blood Glucose Regulators Sales Value by Region (%), (2019-2030)
5.2 Global Oral Blood Glucose Regulators Sales Volume by Region
5.2.1 Global Oral Blood Glucose Regulators Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Oral Blood Glucose Regulators Sales Volume by Region (2019-2024)
5.2.3 Global Oral Blood Glucose Regulators Sales Volume by Region (2025-2030)
5.2.4 Global Oral Blood Glucose Regulators Sales Volume by Region (%), (2019-2030)
5.3 Global Oral Blood Glucose Regulators Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Oral Blood Glucose Regulators Sales Value, 2019-2030
5.4.2 North America Oral Blood Glucose Regulators Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Oral Blood Glucose Regulators Sales Value, 2019-2030
5.5.2 Europe Oral Blood Glucose Regulators Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Oral Blood Glucose Regulators Sales Value, 2019-2030
5.6.2 Asia Pacific Oral Blood Glucose Regulators Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Oral Blood Glucose Regulators Sales Value, 2019-2030
5.7.2 South America Oral Blood Glucose Regulators Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Oral Blood Glucose Regulators Sales Value, 2019-2030
5.8.2 Middle East & Africa Oral Blood Glucose Regulators Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Oral Blood Glucose Regulators Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Oral Blood Glucose Regulators Sales Value
6.2.1 Key Countries/Regions Oral Blood Glucose Regulators Sales Value, 2019-2030
6.2.2 Key Countries/Regions Oral Blood Glucose Regulators Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Oral Blood Glucose Regulators Sales Value, 2019-2030
6.3.2 United States Oral Blood Glucose Regulators Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Oral Blood Glucose Regulators Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Oral Blood Glucose Regulators Sales Value, 2019-2030
6.4.2 Europe Oral Blood Glucose Regulators Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Oral Blood Glucose Regulators Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Oral Blood Glucose Regulators Sales Value, 2019-2030
6.5.2 China Oral Blood Glucose Regulators Sales Value by Type (%), 2023 VS 2030
6.5.3 China Oral Blood Glucose Regulators Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Oral Blood Glucose Regulators Sales Value, 2019-2030
6.6.2 Japan Oral Blood Glucose Regulators Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Oral Blood Glucose Regulators Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Oral Blood Glucose Regulators Sales Value, 2019-2030
6.7.2 South Korea Oral Blood Glucose Regulators Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Oral Blood Glucose Regulators Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Oral Blood Glucose Regulators Sales Value, 2019-2030
6.8.2 Southeast Asia Oral Blood Glucose Regulators Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Oral Blood Glucose Regulators Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Oral Blood Glucose Regulators Sales Value, 2019-2030
6.9.2 India Oral Blood Glucose Regulators Sales Value by Type (%), 2023 VS 2030
6.9.3 India Oral Blood Glucose Regulators Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Bayer
7.1.1 Bayer Company Information
7.1.2 Bayer Introduction and Business Overview
7.1.3 Bayer Oral Blood Glucose Regulators Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Bayer Oral Blood Glucose Regulators Product Offerings
7.1.5 Bayer Recent Development
7.2 Merck
7.2.1 Merck Company Information
7.2.2 Merck Introduction and Business Overview
7.2.3 Merck Oral Blood Glucose Regulators Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Merck Oral Blood Glucose Regulators Product Offerings
7.2.5 Merck Recent Development
7.3 Novartis
7.3.1 Novartis Company Information
7.3.2 Novartis Introduction and Business Overview
7.3.3 Novartis Oral Blood Glucose Regulators Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Novartis Oral Blood Glucose Regulators Product Offerings
7.3.5 Novartis Recent Development
7.4 Huadong Medicine
7.4.1 Huadong Medicine Company Information
7.4.2 Huadong Medicine Introduction and Business Overview
7.4.3 Huadong Medicine Oral Blood Glucose Regulators Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Huadong Medicine Oral Blood Glucose Regulators Product Offerings
7.4.5 Huadong Medicine Recent Development
7.5 Sanofi
7.5.1 Sanofi Company Information
7.5.2 Sanofi Introduction and Business Overview
7.5.3 Sanofi Oral Blood Glucose Regulators Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Sanofi Oral Blood Glucose Regulators Product Offerings
7.5.5 Sanofi Recent Development
7.6 Novo Nordisk
7.6.1 Novo Nordisk Company Information
7.6.2 Novo Nordisk Introduction and Business Overview
7.6.3 Novo Nordisk Oral Blood Glucose Regulators Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Novo Nordisk Oral Blood Glucose Regulators Product Offerings
7.6.5 Novo Nordisk Recent Development
7.7 Servier
7.7.1 Servier Company Information
7.7.2 Servier Introduction and Business Overview
7.7.3 Servier Oral Blood Glucose Regulators Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Servier Oral Blood Glucose Regulators Product Offerings
7.7.5 Servier Recent Development
7.8 Takeda Pharmaceutical
7.8.1 Takeda Pharmaceutical Company Information
7.8.2 Takeda Pharmaceutical Introduction and Business Overview
7.8.3 Takeda Pharmaceutical Oral Blood Glucose Regulators Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Takeda Pharmaceutical Oral Blood Glucose Regulators Product Offerings
7.8.5 Takeda Pharmaceutical Recent Development
7.9 Luye Pharmaceutical
7.9.1 Luye Pharmaceutical Company Information
7.9.2 Luye Pharmaceutical Introduction and Business Overview
7.9.3 Luye Pharmaceutical Oral Blood Glucose Regulators Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Luye Pharmaceutical Oral Blood Glucose Regulators Product Offerings
7.9.5 Luye Pharmaceutical Recent Development
7.10 Taiji Group
7.10.1 Taiji Group Company Information
7.10.2 Taiji Group Introduction and Business Overview
7.10.3 Taiji Group Oral Blood Glucose Regulators Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Taiji Group Oral Blood Glucose Regulators Product Offerings
7.10.5 Taiji Group Recent Development
7.11 CR Double-Crane
7.11.1 CR Double-Crane Company Information
7.11.2 CR Double-Crane Introduction and Business Overview
7.11.3 CR Double-Crane Oral Blood Glucose Regulators Sales, Revenue and Gross Margin (2019-2024)
7.11.4 CR Double-Crane Oral Blood Glucose Regulators Product Offerings
7.11.5 CR Double-Crane Recent Development
7.12 AstraZeneca
7.12.1 AstraZeneca Company Information
7.12.2 AstraZeneca Introduction and Business Overview
7.12.3 AstraZeneca Oral Blood Glucose Regulators Sales, Revenue and Gross Margin (2019-2024)
7.12.4 AstraZeneca Oral Blood Glucose Regulators Product Offerings
7.12.5 AstraZeneca Recent Development
7.13 Boehringer Ingelheim
7.13.1 Boehringer Ingelheim Company Information
7.13.2 Boehringer Ingelheim Introduction and Business Overview
7.13.3 Boehringer Ingelheim Oral Blood Glucose Regulators Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Boehringer Ingelheim Oral Blood Glucose Regulators Product Offerings
7.13.5 Boehringer Ingelheim Recent Development
7.14 Qilu Pharmaceutical
7.14.1 Qilu Pharmaceutical Company Information
7.14.2 Qilu Pharmaceutical Introduction and Business Overview
7.14.3 Qilu Pharmaceutical Oral Blood Glucose Regulators Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Qilu Pharmaceutical Oral Blood Glucose Regulators Product Offerings
7.14.5 Qilu Pharmaceutical Recent Development
7.15 Jiangsu Deyuan Pharmaceutical
7.15.1 Jiangsu Deyuan Pharmaceutical Company Information
7.15.2 Jiangsu Deyuan Pharmaceutical Introduction and Business Overview
7.15.3 Jiangsu Deyuan Pharmaceutical Oral Blood Glucose Regulators Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Jiangsu Deyuan Pharmaceutical Oral Blood Glucose Regulators Product Offerings
7.15.5 Jiangsu Deyuan Pharmaceutical Recent Development
7.16 CTTQ
7.16.1 CTTQ Company Information
7.16.2 CTTQ Introduction and Business Overview
7.16.3 CTTQ Oral Blood Glucose Regulators Sales, Revenue and Gross Margin (2019-2024)
7.16.4 CTTQ Oral Blood Glucose Regulators Product Offerings
7.16.5 CTTQ Recent Development
8 Industry Chain Analysis
8.1 Oral Blood Glucose Regulators Industrial Chain
8.2 Oral Blood Glucose Regulators Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Oral Blood Glucose Regulators Sales Model
8.5.2 Sales Channel
8.5.3 Oral Blood Glucose Regulators Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Oral Blood Glucose Regulators Market Trends
    Table 2. Oral Blood Glucose Regulators Market Drivers & Opportunity
    Table 3. Oral Blood Glucose Regulators Market Challenges
    Table 4. Oral Blood Glucose Regulators Market Restraints
    Table 5. Global Oral Blood Glucose Regulators Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Oral Blood Glucose Regulators Revenue Market Share by Company (2019-2024)
    Table 7. Global Oral Blood Glucose Regulators Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Oral Blood Glucose Regulators Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Oral Blood Glucose Regulators Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Oral Blood Glucose Regulators Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Oral Blood Glucose Regulators Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Oral Blood Glucose Regulators
    Table 13. Global Oral Blood Glucose Regulators Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Blood Glucose Regulators as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Oral Blood Glucose Regulators Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Oral Blood Glucose Regulators Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Oral Blood Glucose Regulators Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Oral Blood Glucose Regulators Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Oral Blood Glucose Regulators Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Oral Blood Glucose Regulators Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Oral Blood Glucose Regulators Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Oral Blood Glucose Regulators Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Oral Blood Glucose Regulators Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Oral Blood Glucose Regulators Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Oral Blood Glucose Regulators Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Oral Blood Glucose Regulators Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Oral Blood Glucose Regulators Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Oral Blood Glucose Regulators Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Oral Blood Glucose Regulators Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Oral Blood Glucose Regulators Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Oral Blood Glucose Regulators Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Oral Blood Glucose Regulators Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Oral Blood Glucose Regulators Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Oral Blood Glucose Regulators Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Oral Blood Glucose Regulators Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Oral Blood Glucose Regulators Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Oral Blood Glucose Regulators Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Oral Blood Glucose Regulators Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Oral Blood Glucose Regulators Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Oral Blood Glucose Regulators Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Oral Blood Glucose Regulators Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Oral Blood Glucose Regulators Sales Value by Region (2019-2024) & (%)
    Table 44. Global Oral Blood Glucose Regulators Sales Value by Region (2025-2030) & (%)
    Table 45. Global Oral Blood Glucose Regulators Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Oral Blood Glucose Regulators Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Oral Blood Glucose Regulators Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Oral Blood Glucose Regulators Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Oral Blood Glucose Regulators Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Oral Blood Glucose Regulators Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Oral Blood Glucose Regulators Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Oral Blood Glucose Regulators Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Oral Blood Glucose Regulators Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Oral Blood Glucose Regulators Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Oral Blood Glucose Regulators Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Oral Blood Glucose Regulators Sales Volume, (2025-2030) & (K Units)
    Table 57. Bayer Company Information
    Table 58. Bayer Introduction and Business Overview
    Table 59. Bayer Oral Blood Glucose Regulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Bayer Oral Blood Glucose Regulators Product Offerings
    Table 61. Bayer Recent Development
    Table 62. Merck Company Information
    Table 63. Merck Introduction and Business Overview
    Table 64. Merck Oral Blood Glucose Regulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Merck Oral Blood Glucose Regulators Product Offerings
    Table 66. Merck Recent Development
    Table 67. Novartis Company Information
    Table 68. Novartis Introduction and Business Overview
    Table 69. Novartis Oral Blood Glucose Regulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Novartis Oral Blood Glucose Regulators Product Offerings
    Table 71. Novartis Recent Development
    Table 72. Huadong Medicine Company Information
    Table 73. Huadong Medicine Introduction and Business Overview
    Table 74. Huadong Medicine Oral Blood Glucose Regulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Huadong Medicine Oral Blood Glucose Regulators Product Offerings
    Table 76. Huadong Medicine Recent Development
    Table 77. Sanofi Company Information
    Table 78. Sanofi Introduction and Business Overview
    Table 79. Sanofi Oral Blood Glucose Regulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Sanofi Oral Blood Glucose Regulators Product Offerings
    Table 81. Sanofi Recent Development
    Table 82. Novo Nordisk Company Information
    Table 83. Novo Nordisk Introduction and Business Overview
    Table 84. Novo Nordisk Oral Blood Glucose Regulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Novo Nordisk Oral Blood Glucose Regulators Product Offerings
    Table 86. Novo Nordisk Recent Development
    Table 87. Servier Company Information
    Table 88. Servier Introduction and Business Overview
    Table 89. Servier Oral Blood Glucose Regulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Servier Oral Blood Glucose Regulators Product Offerings
    Table 91. Servier Recent Development
    Table 92. Takeda Pharmaceutical Company Information
    Table 93. Takeda Pharmaceutical Introduction and Business Overview
    Table 94. Takeda Pharmaceutical Oral Blood Glucose Regulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Takeda Pharmaceutical Oral Blood Glucose Regulators Product Offerings
    Table 96. Takeda Pharmaceutical Recent Development
    Table 97. Luye Pharmaceutical Company Information
    Table 98. Luye Pharmaceutical Introduction and Business Overview
    Table 99. Luye Pharmaceutical Oral Blood Glucose Regulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Luye Pharmaceutical Oral Blood Glucose Regulators Product Offerings
    Table 101. Luye Pharmaceutical Recent Development
    Table 102. Taiji Group Company Information
    Table 103. Taiji Group Introduction and Business Overview
    Table 104. Taiji Group Oral Blood Glucose Regulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Taiji Group Oral Blood Glucose Regulators Product Offerings
    Table 106. Taiji Group Recent Development
    Table 107. CR Double-Crane Company Information
    Table 108. CR Double-Crane Introduction and Business Overview
    Table 109. CR Double-Crane Oral Blood Glucose Regulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. CR Double-Crane Oral Blood Glucose Regulators Product Offerings
    Table 111. CR Double-Crane Recent Development
    Table 112. AstraZeneca Company Information
    Table 113. AstraZeneca Introduction and Business Overview
    Table 114. AstraZeneca Oral Blood Glucose Regulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. AstraZeneca Oral Blood Glucose Regulators Product Offerings
    Table 116. AstraZeneca Recent Development
    Table 117. Boehringer Ingelheim Company Information
    Table 118. Boehringer Ingelheim Introduction and Business Overview
    Table 119. Boehringer Ingelheim Oral Blood Glucose Regulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Boehringer Ingelheim Oral Blood Glucose Regulators Product Offerings
    Table 121. Boehringer Ingelheim Recent Development
    Table 122. Qilu Pharmaceutical Company Information
    Table 123. Qilu Pharmaceutical Introduction and Business Overview
    Table 124. Qilu Pharmaceutical Oral Blood Glucose Regulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Qilu Pharmaceutical Oral Blood Glucose Regulators Product Offerings
    Table 126. Qilu Pharmaceutical Recent Development
    Table 127. Jiangsu Deyuan Pharmaceutical Company Information
    Table 128. Jiangsu Deyuan Pharmaceutical Introduction and Business Overview
    Table 129. Jiangsu Deyuan Pharmaceutical Oral Blood Glucose Regulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. Jiangsu Deyuan Pharmaceutical Oral Blood Glucose Regulators Product Offerings
    Table 131. Jiangsu Deyuan Pharmaceutical Recent Development
    Table 132. CTTQ Company Information
    Table 133. CTTQ Introduction and Business Overview
    Table 134. CTTQ Oral Blood Glucose Regulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 135. CTTQ Oral Blood Glucose Regulators Product Offerings
    Table 136. CTTQ Recent Development
    Table 137. Key Raw Materials Lists
    Table 138. Raw Materials Key Suppliers Lists
    Table 139. Oral Blood Glucose Regulators Downstream Customers
    Table 140. Oral Blood Glucose Regulators Distributors List
    Table 141. Research Programs/Design for This Report
    Table 142. Key Data Information from Secondary Sources
    Table 143. Key Data Information from Primary Sources
List of Figures
    Figure 1. Oral Blood Glucose Regulators Product Picture
    Figure 2. Global Oral Blood Glucose Regulators Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Oral Blood Glucose Regulators Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Oral Blood Glucose Regulators Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Oral Blood Glucose Regulators Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Oral Blood Glucose Regulators Report Years Considered
    Figure 7. Global Oral Blood Glucose Regulators Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Oral Blood Glucose Regulators Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Oral Blood Glucose Regulators Revenue in 2023
    Figure 10. Oral Blood Glucose Regulators Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Biguanides Picture
    Figure 12. Sulfonylureas Picture
    Figure 13. Meglitinides Picture
    Figure 14. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Picture
    Figure 15. SGLT2 Inhibitors Picture
    Figure 16. Thiazolidinediones Picture
    Figure 17. Alpha-Glucosidase Inhibitors Picture
    Figure 18. Other Picture
    Figure 19. Global Oral Blood Glucose Regulators Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 20. Global Oral Blood Glucose Regulators Sales Value Market Share by Type, 2023 & 2030
    Figure 21. Global Oral Blood Glucose Regulators Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 22. Global Oral Blood Glucose Regulators Sales Volume Market Share by Type, 2023 & 2030
    Figure 23. Global Oral Blood Glucose Regulators Price by Type (2019-2030) & (US$/Unit)
    Figure 24. Product Picture of Hospital
    Figure 25. Product Picture of Clinic
    Figure 26. Product Picture of Other
    Figure 27. Global Oral Blood Glucose Regulators Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 28. Global Oral Blood Glucose Regulators Sales Value Market Share by Application, 2023 & 2030
    Figure 29. Global Oral Blood Glucose Regulators Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 30. Global Oral Blood Glucose Regulators Sales Volume Market Share by Application, 2023 & 2030
    Figure 31. Global Oral Blood Glucose Regulators Price by Application (2019-2030) & (US$/Unit)
    Figure 32. North America Oral Blood Glucose Regulators Sales Value (2019-2030) & (US$ Million)
    Figure 33. North America Oral Blood Glucose Regulators Sales Value by Country (%), 2023 VS 2030
    Figure 34. Europe Oral Blood Glucose Regulators Sales Value (2019-2030) & (US$ Million)
    Figure 35. Europe Oral Blood Glucose Regulators Sales Value by Country (%), 2023 VS 2030
    Figure 36. Asia Pacific Oral Blood Glucose Regulators Sales Value (2019-2030) & (US$ Million)
    Figure 37. Asia Pacific Oral Blood Glucose Regulators Sales Value by Country (%), 2023 VS 2030
    Figure 38. South America Oral Blood Glucose Regulators Sales Value (2019-2030) & (US$ Million)
    Figure 39. South America Oral Blood Glucose Regulators Sales Value by Country (%), 2023 VS 2030
    Figure 40. Middle East & Africa Oral Blood Glucose Regulators Sales Value (2019-2030) & (US$ Million)
    Figure 41. Middle East & Africa Oral Blood Glucose Regulators Sales Value by Country (%), 2023 VS 2030
    Figure 42. Key Countries/Regions Oral Blood Glucose Regulators Sales Value (%), (2019-2030)
    Figure 43. Key Countries/Regions Oral Blood Glucose Regulators Sales Volume (%), (2019-2030)
    Figure 44. United States Oral Blood Glucose Regulators Sales Value, (2019-2030) & (US$ Million)
    Figure 45. United States Oral Blood Glucose Regulators Sales Value by Type (%), 2023 VS 2030
    Figure 46. United States Oral Blood Glucose Regulators Sales Value by Application (%), 2023 VS 2030
    Figure 47. Europe Oral Blood Glucose Regulators Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Europe Oral Blood Glucose Regulators Sales Value by Type (%), 2023 VS 2030
    Figure 49. Europe Oral Blood Glucose Regulators Sales Value by Application (%), 2023 VS 2030
    Figure 50. China Oral Blood Glucose Regulators Sales Value, (2019-2030) & (US$ Million)
    Figure 51. China Oral Blood Glucose Regulators Sales Value by Type (%), 2023 VS 2030
    Figure 52. China Oral Blood Glucose Regulators Sales Value by Application (%), 2023 VS 2030
    Figure 53. Japan Oral Blood Glucose Regulators Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Japan Oral Blood Glucose Regulators Sales Value by Type (%), 2023 VS 2030
    Figure 55. Japan Oral Blood Glucose Regulators Sales Value by Application (%), 2023 VS 2030
    Figure 56. South Korea Oral Blood Glucose Regulators Sales Value, (2019-2030) & (US$ Million)
    Figure 57. South Korea Oral Blood Glucose Regulators Sales Value by Type (%), 2023 VS 2030
    Figure 58. South Korea Oral Blood Glucose Regulators Sales Value by Application (%), 2023 VS 2030
    Figure 59. Southeast Asia Oral Blood Glucose Regulators Sales Value, (2019-2030) & (US$ Million)
    Figure 60. Southeast Asia Oral Blood Glucose Regulators Sales Value by Type (%), 2023 VS 2030
    Figure 61. Southeast Asia Oral Blood Glucose Regulators Sales Value by Application (%), 2023 VS 2030
    Figure 62. India Oral Blood Glucose Regulators Sales Value, (2019-2030) & (US$ Million)
    Figure 63. India Oral Blood Glucose Regulators Sales Value by Type (%), 2023 VS 2030
    Figure 64. India Oral Blood Glucose Regulators Sales Value by Application (%), 2023 VS 2030
    Figure 65. Oral Blood Glucose Regulators Industrial Chain
    Figure 66. Oral Blood Glucose Regulators Manufacturing Cost Structure
    Figure 67. Channels of Distribution (Direct Sales, and Distribution)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS